デフォルト表紙
市場調査レポート
商品コード
1463775

消化管ステントの世界市場:市場規模・シェア分析 (製品別・用途別・材料別・種類別・エンドユーザー別)、産業需要の予測 (~2030年)

Gastrointestinal Stent Market Size and Share Analysis by Product, Application, Material, Type, End User - Global Industry Demand Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 290 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
消化管ステントの世界市場:市場規模・シェア分析 (製品別・用途別・材料別・種類別・エンドユーザー別)、産業需要の予測 (~2030年)
出版日: 2024年03月27日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 290 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の消化管ステント市場は、2023年に5億2,550万米ドルの売上を計上しました。2024年から2030年にかけてのCAGRは6.0%で、最終的に2030年には7億8,190万米ドルに達すると予測されています。この成長は、消化器がんやその他の消化器疾患の発生が増加していること、憩室症や腸の病気を含む消化器疾患を抱える高齢化人口が増加していることに起因しています。

主な洞察

2023年、胆道ステントカテゴリーは35%と最大の収入シェアを占めました。

閉塞性黄疸の発生が増加しており、悪性疾患や良性疾患に起因する可能性があるため、覇権を維持すると予測されています。

自己拡張型金属ステント (SEMS) カテゴリーは、業界で最大のシェア40%を占めています。

これらのステントは、高い有効性、より長い効力、挿入の容易さ、移動または脱落リスクの低さなどの利点があるため、優位性を維持すると予測されています。

2023年、薬剤溶出ステントカテゴリーは、消化管ステント業界でより大きな収益シェアを生み出しました。

このカテゴリーは、標的血管の再灌流が減少し、関連疾患の危険性が減少するなどの利点があるため、覇権を維持すると予測されています。

2023年には、北米地域の売上高シェアが約50%と最も大きく、予測期間中のCAGRは堅調に推移する見込みです。

その背景には、可処分所得や医療費の高さ、消化管に問題を抱える人口の高齢化、低侵襲手術の高い受容率などがあります。

当レポートでは、世界の消化管ステントの市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017~2030年)、製品別・用途別・材料別・種類別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)
  • 市場収益:材料別 (2017~2030年)
    • SEMSの市場収益:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場収益:エンドユーザー別 (2017~2030年)
  • 市場収益:地域別 (2017~2030年)

第7章 北米市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)
  • 市場収益:材料別 (2017~2030年)
    • SEMSの市場収益:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場収益:エンドユーザー別 (2017~2030年)
  • 市場収益:国別 (2017~2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ市場

第12章 米国市場

  • 概要
  • 市場収益:製品別 (2017~2030年)
  • 市場収益:用途別 (2017~2030年)
  • 市場収益:材料別 (2017~2030年)
    • SEMSの市場収益:種類別 (2017~2030年)
  • 市場収益:種類別 (2017~2030年)
  • 市場収益:エンドユーザー別 (2017~2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • Boston Scientific Corporation
  • Medtronic plc
  • Becton, Dickinson and Company
  • CONMED Corporation
  • Olympus Corporation
  • Cook Group Incorporated
  • HOBBS MEDICAL INC.
  • Merit Medical Systems
  • W. L. Gore & Associates Inc.

第31章 付録

目次
Product Code: 12832

Market Overview

The worldwide gastrointestinal stent market amassed USD 525.5 million in revenue in 2023. It is anticipated to experience a Compound Annual Growth Rate (CAGR) of 6.0% between 2024 and 2030, ultimately reaching USD 781.9 million by 2030. This growth can be credited to the increasing occurrence of gastrointestinal cancers and other peptic issues and the rising aging populace with gastrointestinal illnesses including diverticulosis and bowel sicknesses.

A major cause of death globally is stomach cancer which is a product of the gastrointestinal system. Most of the patients in recent years have been dying or sicker from chronic diseases such as colorectal cancer, esophageal cancer, and GI-related critical illnesses.

According to a new study released by the International Agency for Research on Cancer (IARC) in July 2020, colorectal cancer took away 35% of all deaths and 26% of all new incidences on the global map, and in 2018, IARC cites that there were approximately 4.8 million of colon cancer sufferers and 3.4 million

Furthermore, the increasing prevalence of Crohn's disease in all socio-economic sections of society stands behind the demand. As indicated by the Crohn's & Colitis Foundation, in 2020, three-quarters of all patients with Crohn's disease had one or more procedures at some point in their history.

Key Insights

In 2023, the biliary stent category had the largest income share of 35%.

It is projected to uphold its supremacy because of the growing occurrence of obstructive jaundice, which can outcome from malignant or benign disease.

Biliary stents are utilized to cure obstructions in the biliary tree or biliary leaks.

Minimally invasive endoscopic stent placement is now the most effective treatment choice for serious benign bile duct strictures.

The Self-expanding metal stents category had the largest share of 40% in the industry.

They are projected to uphold supremacy because of benefits such as high effectiveness, lengthier potency, ease of insertion, and low migration or dislodgment risk.

Such stents are utilized for handling benign gastrointestinal leaks and perforations.

Metal stents are characteristically made of nitinol, stainless steel, and cobalt-chromium, offering backing to keep the GI tract open for unobstructed drainage.

The drug-eluting stent category had a larger revenue share in the gastrointestinal stent market in 2023.

In 2023, the drug-eluting stent category generated a larger revenue share in the gastrointestinal stent industry.

The category is also projected to uphold its supremacy because of benefits such as decreased target-vessel revascularization and reduced danger of associated diseases.

Such stents efficiently release medication and have seen improvements like biodegradability.

The slow release of medicine is a major advantage contributing to the efficiency of drug-eluting stents.

In 2023, the North American region had the largest revenue share of approximately 50%, with prospects of strong CAGR development over the projection period.

Reasons propelling this include high disposable income, healthcare spending, a huge aging populace with gastrointestinal problems, and a high acceptance rate of minimally invasive operations.

The region's market growth will be driven by the existence of an ideal after-payment structure and the emergence of new cases of GI diseases as well.

The Canadian market looks very promising because the emerging medical equipment infrastructure, government initiatives, as well as the high demand for minimally invasive surgeries, are the factors contributing to this development.

The vast European market is anticipated to demonstrate high growth powered by the growing healthcare infrastructure advancements, as well as the increase in the number of chronic diseases and favorable reimbursement policies.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by application
    • 1.4.3. Market size breakdown, by material
    • 1.4.4. Market size breakdown, by type
    • 1.4.5. Market size breakdown, by end user
    • 1.4.6. Market size breakdown, by region
    • 1.4.7. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
  • 6.3. Market Revenue, by Application (2017-2030)
  • 6.4. Market Revenue, by Material (2017-2030)
    • 6.4.1. SEMSs market revenue, by type (2017-2030)
  • 6.5. Market Revenue, by Type (2017-2030)
  • 6.6. Market Revenue, by End User (2017-2030)
  • 6.7. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
  • 7.3. Market Revenue, by Application (2017-2030)
  • 7.4. Market Revenue, by Material (2017-2030)
    • 7.4.1. SEMSs market revenue, by type (2017-2030)
  • 7.5. Market Revenue, by Type (2017-2030)
  • 7.6. Market Revenue, by End User (2017-2030)
  • 7.7. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
  • 8.3. Market Revenue, by Application (2017-2030)
  • 8.4. Market Revenue, by Material (2017-2030)
    • 8.4.1. SEMSs market revenue, by type (2017-2030)
  • 8.5. Market Revenue, by Type (2017-2030)
  • 8.6. Market Revenue, by End User (2017-2030)
  • 8.7. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
  • 9.3. Market Revenue, by Application (2017-2030)
  • 9.4. Market Revenue, by Material (2017-2030)
    • 9.4.1. SEMSs market revenue, by type (2017-2030)
  • 9.5. Market Revenue, by Type (2017-2030)
  • 9.6. Market Revenue, by End User (2017-2030)
  • 9.7. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
  • 10.3. Market Revenue, by Application (2017-2030)
  • 10.4. Market Revenue, by Material (2017-2030)
    • 10.4.1. SEMSs market revenue, by type (2017-2030)
  • 10.5. Market Revenue, by Type (2017-2030)
  • 10.6. Market Revenue, by End User (2017-2030)
  • 10.7. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
  • 11.3. Market Revenue, by Application (2017-2030)
  • 11.4. Market Revenue, by Material (2017-2030)
    • 11.4.1. SEMSs market revenue, by type (2017-2030)
  • 11.5. Market Revenue, by Type (2017-2030)
  • 11.6. Market Revenue, by End User (2017-2030)
  • 11.7. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
  • 12.3. Market Revenue, by Application (2017-2030)
  • 12.4. Market Revenue, by Material (2017-2030)
    • 12.4.1. SEMSs market revenue, by type (2017-2030)
  • 12.5. Market Revenue, by Type (2017-2030)
  • 12.6. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
  • 13.3. Market Revenue, by Application (2017-2030)
  • 13.4. Market Revenue, by Material (2017-2030)
    • 13.4.1. SEMSs market revenue, by type (2017-2030)
  • 13.5. Market Revenue, by Type (2017-2030)
  • 13.6. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
  • 14.3. Market Revenue, by Application (2017-2030)
  • 14.4. Market Revenue, by Material (2017-2030)
    • 14.4.1. SEMSs market revenue, by type (2017-2030)
  • 14.5. Market Revenue, by Type (2017-2030)
  • 14.6. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
  • 15.3. Market Revenue, by Application (2017-2030)
  • 15.4. Market Revenue, by Material (2017-2030)
    • 15.4.1. SEMSs market revenue, by type (2017-2030)
  • 15.5. Market Revenue, by Type (2017-2030)
  • 15.6. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
  • 16.3. Market Revenue, by Application (2017-2030)
  • 16.4. Market Revenue, by Material (2017-2030)
    • 16.4.1. SEMSs market revenue, by type (2017-2030)
  • 16.5. Market Revenue, by Type (2017-2030)
  • 16.6. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
  • 17.3. Market Revenue, by Application (2017-2030)
  • 17.4. Market Revenue, by Material (2017-2030)
    • 17.4.1. SEMSs market revenue, by type (2017-2030)
  • 17.5. Market Revenue, by Type (2017-2030)
  • 17.6. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
  • 18.3. Market Revenue, by Application (2017-2030)
  • 18.4. Market Revenue, by Material (2017-2030)
    • 18.4.1. SEMSs market revenue, by type (2017-2030)
  • 18.5. Market Revenue, by Type (2017-2030)
  • 18.6. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
  • 19.3. Market Revenue, by Application (2017-2030)
  • 19.4. Market Revenue, by Material (2017-2030)
    • 19.4.1. SEMSs market revenue, by type (2017-2030)
  • 19.5. Market Revenue, by Type (2017-2030)
  • 19.6. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
  • 20.3. Market Revenue, by Application (2017-2030)
  • 20.4. Market Revenue, by Material (2017-2030)
    • 20.4.1. SEMSs market revenue, by type (2017-2030)
  • 20.5. Market Revenue, by Type (2017-2030)
  • 20.6. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
  • 21.3. Market Revenue, by Application (2017-2030)
  • 21.4. Market Revenue, by Material (2017-2030)
    • 21.4.1. SEMSs market revenue, by type (2017-2030)
  • 21.5. Market Revenue, by Type (2017-2030)
  • 21.6. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
  • 22.3. Market Revenue, by Application (2017-2030)
  • 22.4. Market Revenue, by Material (2017-2030)
    • 22.4.1. SEMSs market revenue, by type (2017-2030)
  • 22.5. Market Revenue, by Type (2017-2030)
  • 22.6. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
  • 23.3. Market Revenue, by Application (2017-2030)
  • 23.4. Market Revenue, by Material (2017-2030)
    • 23.4.1. SEMSs market revenue, by type (2017-2030)
  • 23.5. Market Revenue, by Type (2017-2030)
  • 23.6. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
  • 24.3. Market Revenue, by Application (2017-2030)
  • 24.4. Market Revenue, by Material (2017-2030)
    • 24.4.1. SEMSs market revenue, by type (2017-2030)
  • 24.5. Market Revenue, by Type (2017-2030)
  • 24.6. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
  • 25.3. Market Revenue, by Application (2017-2030)
  • 25.4. Market Revenue, by Material (2017-2030)
    • 25.4.1. SEMSs market revenue, by type (2017-2030)
  • 25.5. Market Revenue, by Type (2017-2030)
  • 25.6. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
  • 26.3. Market Revenue, by Application (2017-2030)
  • 26.4. Market Revenue, by Material (2017-2030)
    • 26.4.1. SEMSs market revenue, by type (2017-2030)
  • 26.5. Market Revenue, by Type (2017-2030)
  • 26.6. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
  • 27.3. Market Revenue, by Application (2017-2030)
  • 27.4. Market Revenue, by Material (2017-2030)
    • 27.4.1. SEMSs market revenue, by type (2017-2030)
  • 27.5. Market Revenue, by Type (2017-2030)
  • 27.6. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
  • 28.3. Market Revenue, by Application (2017-2030)
  • 28.4. Market Revenue, by Material (2017-2030)
    • 28.4.1. SEMSs market revenue, by type (2017-2030)
  • 28.5. Market Revenue, by Type (2017-2030)
  • 28.6. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Boston Scientific Corporation
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Medtronic plc
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Becton, Dickinson and Company
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. CONMED Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Olympus Corporation
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Cook Group Incorporated
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. HOBBS MEDICAL INC.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Merit Medical Systems
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. W. L. Gore & Associates Inc.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports